Artelo Biosciences Reports First Quarter Fiscal Year 2020 Financial Results and Provides Business Update

LA JOLLA, Calif., Jan. 14, 2020 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company focused on the development of therapeutics that modulate the endocannabinoid system, today reported financial and operating results for the first quarter of its fiscal year ended November 30, 2019.

Click to view original post